WO2021224902 - AN IMPROVED PROCESS FOR THE PREPARATION OF AN AQUEOUS OPHTHALMIC SOLUTION OF DIFLUPREDNATE

National phase entry:
Publication Number WO/2021/224902
Publication Date 11.11.2021
International Application No. PCT/IB2021/059213
International Filing Date 07.10.2021
Title **
[English] AN IMPROVED PROCESS FOR THE PREPARATION OF AN AQUEOUS OPHTHALMIC SOLUTION OF DIFLUPREDNATE
[French] PROCÉDÉ AMÉLIORÉ POUR LA PRÉPARATION D'UNE SOLUTION OPHTALMIQUE AQUEUSE DE DIFLUPREDNATE
Applicants **
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
Inventors
HALDER, Arindam
KHOPADE, Ajay Jaysingh
Priority Data
202121038494   25.08.2021   IN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting1959
EPO Filing, Examination, Granting11777
Japan Filing, Examination, Granting2010
South Korea Filing, Examination, Granting1712
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 22,198

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The present invention relates an improved process for the preparation of an aqueous ophthalmic solution of difluprednate or pharmaceutically acceptable salts thereof. The present invention further relates to an aqueous ophthalmic solution of difluprednate or pharmaceutically acceptable salts thereof, prepared by the improved process of the present invention.[French] La présente invention concerne un procédé amélioré pour la préparation d'une solution ophtalmique aqueuse de difluprednate ou de sels pharmaceutiquement acceptables de celui-ci. La présente invention concerne en outre une solution ophtalmique aqueuse de difluprednate ou de sels pharmaceutiquement acceptables de celui-ci, préparée par le procédé amélioré de la présente invention.

Rejoining the server...